Laboratory Services

Sensiva Health delivers state-of-the-art molecular diagnostics for rapid detection of infectious pathogens, including comprehensive panels for respiratory, UTI/STI, wound, and nail infections. Utilizing real-time PCR with <12-hour turnaround, our assays identify bacteria, viruses, fungi, and antibiotic resistance genes to guide targeted therapy, support antibiotic stewardship, and prevent outbreaks, especially in vulnerable populations. Backed by automated workflows and in-house expertise, we provide actionable insights that reduce unnecessary antibiotics, hospital readmissions, and infection control failures.

Our Germ Line NGS (Next-Generation Sequencing) services analyze inherited genetic variants to assess disease risk, carrier status, and pharmacogenomic implications. With <5-day turnaround and high-throughput sequencing, we deliver comprehensive, clinically relevant insights for hereditary conditions, family planning, and personalized medicine. Integrated with our full diagnostic ecosystem, this service empowers clinicians to make proactive decisions, optimize long-term care, and enhance patient outcomes through precise, data-driven genetic information.

Sensiva Health offers advanced cancer genomics, including liquid biopsy (ctDNA) for non-invasive profiling and FFPE-based solid tumor panels for tissue-based analysis. Detecting >500 actionable alterations (mutations, fusions, amplifications, TMB) across key oncology genes, our assays support precision oncology: therapy selection, resistance monitoring, minimal residual disease tracking, and treatment optimization in lung, breast, colorectal, and pan-tumor settings. With rapid reporting and seamless PGx integration, we help oncologists deliver targeted, effective care while minimizing risks and delays.

Our Pharmacogenomics (PGx) testing analyzes key drug-metabolism genes (including CYP2D6, CYP2C19, CYP2C9, CYP3A4/5, SLCO1B1, VKORC1, and others) to guide personalized medication dosing and selection. Utilizing robotics and our high-throughput platform, we provide actionable insights that reduce adverse drug reactions, optimize therapies (especially in oncology and polypharmacy), and improve safety/efficacy. This service integrates with our cancer genomics and toxicology offerings to support comprehensive precision medicine for complex patients.

Sensiva Health provides definitive, quantitative toxicology testing via triple quadrupole LC-MS/MS for accurate detection of drugs, metabolites, and synthetics in urine or oral fluid. With <24–36 hour turnaround, our panels (100+ targets) support medication adherence monitoring, diversion prevention, polypharmacy risk reduction, and compliance in chronic care and pain management. Prioritizing human expertise and chain-of-custody, we deliver reliable results that inform safer prescribing and enhance patient safety.

Our fully automated blood and chemistry panels (including CBC, CMP, lipid, hepatic, renal, diabetes, hormone, vitamin, and wellness markers) provide rapid, precise insights into organ function, nutrient status, anemia, cardiac health, and overall wellness. With <12-hour turnaround using state-of-the-art Siemens platforms, we enable early detection of chronic conditions, proactive management, and reduced readmissions—particularly for elderly and medically complex patients. Backed by in-house automation and expertise, we ensure sample integrity and actionable results every time.